Definitive Healthcare Reports Q2 2025 Results

Definitive Healthcare Corp. Class A ( (DH) ) has released its Q2 earnings. Here is a breakdown of the information Definitive Healthcare Corp. Class A presented to its investors.

Definitive Healthcare Corp., a leader in healthcare commercial intelligence, provides data-driven insights to help clients navigate the healthcare industry. In its second quarter fiscal year 2025 earnings report, the company announced that its revenue exceeded guidance despite a slight decline from the previous year. The company reported a revenue of $60.8 million, a 5% decrease from the same period last year. However, it significantly reduced its net loss to $9.3 million from $306.2 million in the previous year, which was impacted by substantial goodwill impairment charges. Adjusted EBITDA stood at $18.7 million, representing 31% of revenue, while cash flow from operations was $9.3 million. The company highlighted several strategic customer wins, including a healthcare revenue cycle management firm and a digital health organization, showcasing its competitive edge in data quality and integration capabilities. Looking ahead, Definitive Healthcare has raised its revenue guidance and adjusted EBITDA outlook for the year, reflecting confidence in its strategic direction and ongoing improvements.